Loading...
Pharmacogenetic considerations with dichloroacetate dosing
The investigational drug dichloroacetate (DCA) is a metabolic regulator that has been successfully used to treat acquired and congenital metabolic diseases and, recently, solid tumors. Its clinical use has revealed challenges in selecting appropriate doses. Chronic administration of DCA leads to inh...
Na minha lista:
| Udgivet i: | Pharmacogenomics |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Medicine Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5558523/ https://ncbi.nlm.nih.gov/pubmed/27143230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2015-0012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|